logoTry Persana

zPREDICTA - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about zPREDICTA including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

zPREDICTA company logo

zPREDICTA develops tumor-specific in vitro 3D models to aid drug development, focusing on personalized cancer therapies.

HeadquartersSan Jose, CA, United States
Team size1-10
Founded2014

What is zPREDICTA? - Company Overview & Details

zPREDICTA is zPREDICTA develops tumor-specific in vitro 3D models to aid drug development, focusing on personalized cancer therapies. Founded in 2014, the company is headquartered in San Jose, CA, United States.

Who Founded zPREDICTA?

zPREDICTA is led by CEO J. Melville Engle.

Who are the Key Executives at zPREDICTA? - Leadership Team

zPREDICTA is led by experienced executives in key positions:

Chief Executive Officer (CEO) of zPREDICTA

J. Melville EngleCEO

Chief Technology Officer (CTO) of zPREDICTA

CTO

About J. Melville Engle - CEO of zPREDICTA

J. Melville Engle serves as the Chief Executive Officer of zPREDICTA, leading the company's strategic vision and operations.

zPREDICTA Company Details & Key Information

Where is zPREDICTA located?

zPREDICTA is headquartered in San Jose, CA, United States.

How many employees does zPREDICTA have?

zPREDICTA has 1-10 employees.

When was zPREDICTA founded?

zPREDICTA was founded in 2014.

zPREDICTA Official Website

How much funding has zPREDICTA raised?

zPREDICTA has raised undisclosed amount.

N/A
Total Funding Raised
0
Funding Rounds
N/A
Latest Round

Who are the key investors in zPREDICTA?

Investor Information Not Available

Detailed information about zPREDICTA investors is not currently available in our database.

What are zPREDICTA's future plans?

Future Plans Information Not Available

Detailed information about zPREDICTA's future plans and strategic initiatives is not currently available in our database.

What are the latest news about zPREDICTA?

zPREDICTA has 2 recent news updates covering key business developments and market activities.

zPREDICTA News Overview

2
Recent Articles
Active
Media Coverage
2023-02-03
Latest Update

What is zPREDICTA in the news for?

zPREDICTA is currently featured in news for Zpredicta hired Pamela Bush as Chief Business Officer on Feb 3rd '23. and other significant business developments.

Recent News Articles About zPREDICTA

Article 1
2023-02-03

Zpredicta hired Pamela Bush as Chief Business Officer on Feb 3rd '23.

Predictive Oncology announced the appointment of Pamela Bush, Ph.D., as Chief Business Officer.

yahoo.com
Read News
Article 2
2023-01-12

Zpredicta hired Robert F. Murphy on Jan 12th '23.

Predictive Oncology announced the appointment of Robert F. Murphy, Ph.D., to its Scientific Advisory Board.

marketscreener.com
Read News

zPREDICTA FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about zPREDICTA including information about founders, CEO, funding history, investors, headquarters location, and company details. 10 frequently asked questions covering key information about the company.

zPREDICTA Questions & Answers - Company Information

Q1

What is zPREDICTA?

zPREDICTA develops tumor-specific in vitro 3D models to aid drug development, focusing on personalized cancer therapies.

Q2

Who founded zPREDICTA?

zPREDICTA is led by CEO J. Melville Engle.

Q3

Who is the CEO of zPREDICTA?

The CEO of zPREDICTA is J. Melville Engle.

Q4

Where is zPREDICTA headquartered?

zPREDICTA is headquartered in San Jose, CA, United States.

Q5

When was zPREDICTA founded?

zPREDICTA was founded in 2014.

Q6

How many employees does zPREDICTA have?

zPREDICTA has 1-10 employees.

Q7

What is zPREDICTA's official website?

You can visit zPREDICTA's official website at http://zpredicta.com.

Q8

Who is founder?

J. Melville Engle

Q9

What does the company do?

zPREDICTA develops tumor-specific in vitro 3D models to aid drug development, focusing on personalized cancer therapies.

Q10

Latest news?

Predictive Oncology announced the appointment of Pamela Bush, Ph.D., as Chief Business Officer. Predictive Oncology announced the appointment of Robert F. Murphy, Ph.D., to its Scientific Advisory Board.

More Information About zPREDICTA

For additional details about zPREDICTA, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.